# Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery

> **NCT03383198** · PHASE4 · TERMINATED · sponsor: **Prisma Health-Upstate** · enrollment: 5 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Liposomal bupivacaine right injection
- **DRUG:** Liposomal bupivacaine left injection

## Key facts

- **NCT ID:** NCT03383198
- **Lead sponsor:** Prisma Health-Upstate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Early termination due to manufacturer discontinued supplying the product for the study.
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03383198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03383198, "Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03383198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*